Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Liver Diseases

  Free Subscription


5 BMC Cancer
1 BMC Gastroenterol
1 Br J Surg
2 Dig Dis Sci
1 Gastroenterology
1 Gut
6 Hepatology
1 Int J Cancer
1 J Gastroenterol Hepatol
2 J Hepatol
1 Radiology
1 Semin Liver Dis
2 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Cancer

  1. PRADIER MF, Reis B, Jukofsky L, Milletti F, et al
    Case-control Indian buffet process identifies biomarkers of response to Codrituzumab.
    BMC Cancer. 2019;19:278.
    PubMed     Text format     Abstract available

  2. AOKI S, Motoi F, Murakami Y, Sho M, et al
    Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients.
    BMC Cancer. 2019;19:252.
    PubMed     Text format     Abstract available

  3. NG L, Kwan V, Chow A, Yau TC, et al
    Overexpression of Pin1 and rho signaling partners correlates with metastatic behavior and poor recurrence-free survival of hepatocellular carcinoma patients.
    BMC Cancer. 2019;19:713.
    PubMed     Text format     Abstract available

  4. TORRESI J, Tran BM, Christiansen D, Earnest-Silveira L, et al
    HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models.
    BMC Cancer. 2019;19:707.
    PubMed     Text format     Abstract available

  5. LIU B, Long J, Wang W, Huang T, et al
    Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study.
    BMC Cancer. 2019;19:699.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  6. SAVARI F, Mard SA, Badavi M, Rezaie A, et al
    A new method to induce nonalcoholic steatohepatitis (NASH) in mice.
    BMC Gastroenterol. 2019;19:125.
    PubMed     Text format     Abstract available

    Br J Surg

  7. VAN ROSMALEN BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, et al
    Safety and efficacy of transarterial embolization of hepatocellular adenomas.
    Br J Surg. 2019 Jul 17. doi: 10.1002/bjs.11213.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  8. SAMJI NS, Verma R, Keri KC, Singal AK, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05716.
    PubMed     Text format     Abstract available

  9. SONG Q, Ren W, Fan L, Zhao M, et al
    Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Dig Dis Sci. 2019 Jul 17. pii: 10.1007/s10620-019-05733.
    PubMed     Text format     Abstract available


  10. LO GH
    The transplantation of fecal microbiota for cirrhotic patients.
    Gastroenterology. 2019 Jul 12. pii: S0016-5085(19)41090.
    PubMed     Text format    


  11. GUERRA MT, Florentino RM, Franca A, Lima Filho AC, et al
    Expression of the type 3 InsP3 receptor is a final common event in the development of hepatocellular carcinoma.
    Gut. 2019 Jul 17. pii: gutjnl-2018-317811. doi: 10.1136/gutjnl-2018-317811.
    PubMed     Text format     Abstract available


  12. CHOI HSJ, Brouwer WP, Zanjir WMR, de Man RA, et al
    Non-Alcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B.
    Hepatology. 2019 Jul 15. doi: 10.1002/hep.30857.
    PubMed     Text format     Abstract available

  13. YANG JD, Ahmed F, Mara KC, Addissie BD, et al
    Diabetes is Associated with Increased Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease.
    Hepatology. 2019 Jul 15. doi: 10.1002/hep.30858.
    PubMed     Text format     Abstract available

  14. MAIWALL R, Rao Pasupuleti SS, Bihari C, Rastogi A, et al
    Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study.
    Hepatology. 2019 Jul 16. doi: 10.1002/hep.30859.
    PubMed     Text format     Abstract available

  15. ALLER MA, Arias J, Blanco-Rivero J
    The porto-hepatic spectrum of cirrhotic encephalopathy.
    Hepatology. 2019 Jul 17. doi: 10.1002/hep.30860.
    PubMed     Text format     Abstract available

  16. DA BL, Surana P, Kapuria D, Vittal A, et al
    Portal Pressure in Non-Cirrhotic Portal Hypertension: To Measure or Not to Measure.
    Hepatology. 2019 Jul 18. doi: 10.1002/hep.30862.
    PubMed     Text format     Abstract available

  17. LO GH
    Letter of Editor: Colder weather and fewer sunlight hours truly increase alcohol consumption and alcoholic cirrhosis ?
    Hepatology. 2019 Jul 19. doi: 10.1002/hep.30865.
    PubMed     Text format     Abstract available

    Int J Cancer

  18. HU B, Li H, Guo W, Sun YF, et al
    Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification.
    Int J Cancer. 2019 Jul 16. doi: 10.1002/ijc.32564.
    PubMed     Text format     Abstract available

    J Gastroenterol Hepatol

  19. GUEDES TP, Fernandes B, Pedroto I
    Hepatobiliary and Pancreatic: Symptomatic hepatic splenosis.
    J Gastroenterol Hepatol. 2019 Jul 18. doi: 10.1111/jgh.14743.
    PubMed     Text format    

    J Hepatol

  20. ANGELI P, Garcia-Tsao G, Nadim MK, Parikh CR, et al
    News in Pathophysiology, Definition and Classification of Hepatorenal Syndrome: a step beyond the International Club of Ascites (ICA) Consensus document.
    J Hepatol. 2019 Jul 11. pii: S0168-8278(19)30410.
    PubMed     Text format     Abstract available

  21. LOGLIO A, Ferenci P, Colonia Uceda Renteria S, Tham CYL, et al
    Excellent safety and effectiveness of high dose myrcludex-b monotherapy administered for 48 weeks in hdv related compensated cirrhosis: a case report of three patients.
    J Hepatol. 2019 Jul 11. pii: S0168-8278(19)30411.
    PubMed     Text format     Abstract available


  22. LEE SM, Lee JM, Ahn SJ, Kang HJ, et al
    LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
    Radiology. 2019 Jul 16:182867. doi: 10.1148/radiol.2019182867.
    PubMed     Text format     Abstract available

    Semin Liver Dis

  23. BRUSILOVSKAYA K, Konigshofer P, Schwabl P, Reiberger T, et al
    Vascular Targets for the Treatment of Portal Hypertension.
    Semin Liver Dis. 2019 Jul 17. doi: 10.1055/s-0039-1693115.
    PubMed     Text format     Abstract available

    Transplant Proc

  24. ISLEK A, Keskin H, Agin M, Aksungur N, et al
    Parvovirus B19 Infection as a Rare Cause of Fulminant Liver Failure: A Case Report.
    Transplant Proc. 2019;51:1169-1171.
    PubMed     Text format     Abstract available

  25. KIM E, Choi DL, Jung JY, Byun SH, et al
    Erratum: Erratum to'Shift in Sympathovagal Balance Toward Parasympathetic Predominance Is Associated With Attenuation of Portal Hyperperfusion in Cirrhotic Recipients Undergoing Living Donor Liver Transplant' [Transplant Proc 51 (2019) 1511-1515].
    Transplant Proc. 2019 Jul 12. pii: S0041-1345(19)30894.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.